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ABSTRACT		Acute	 myeloid	 leukemia	 (AML)	 is	 a	 heterogeneous	 clonal	 disorder	 characterized	 by	 a	misregulation	 in	 the	 differentiation	 program	 of	 myeloid	 progenitor	 cells	 that	 proliferate	abnormally	and	arrest	in	their	maturation.	In	the	effort	to	reveal	the	mechanism	that	confers	self-renewal	potential	to	Leukemia	Stem	Cells	(LSCs),	Wnt	pathway	came	out	as	a	candidate.	The	Wnt	pathway	has	a	central	role	in	the	hematopoiesis	regulating	the	hematopoietic	stem	cells	(HSCs)	self-renewal.	A	recent	study	showed	an	increase	of	WNT	proteins	(i.e.	WNT10B)	expression	and	release	within	the	microenvironment	in	both	leukemic	blasts	and	stromal-like	cells	 of	 AML	 patients,	 indicating	 its	 possible	 autocrine/paracrine	 involvement	 in	 the	 bone	marrow	microenvironment,	 and	 suggesting	 that	 the	 regenerative	WNT	 signaling	 is	 a	 stem	cell-associated	function	altered	in	AML	stem	cell	fraction.	The	aim	of	this	work	is	to	elucidate	the	 role	 of	 WNT10B	 in	 AML	 generating	 an	 animal	 model	 in	 which	 this	 signaling	 is	disregulated.	The	striking	similarities	of	zebrafish	and	human	hematopoiesis	make	this	fish	an	excellent	 model	 for	 elucidating	 physiologic	 and	 pathological	 mechanisms.	 Furthermore,	various	 hematopoietic	 zebrafish	 mutants,	 mimicking	 the	 human	 hematopoietic	 system	diseases,	have	been	generated.	wnt10b	was	transiently	upregulated	in	zebrafish	embryos	and	effects	 of	 such	 misregulation	 on	 embryonic	 hematopoiesis	 were	 analyzed.	 In-situ	hybridization	assays,	performed	using	myeloid	and	HSCs	markers	(pu.1	and	scl,	respectively),	and	 in	vivo	observation	of	 transgenic	 fish	 lines	 expressing	 fluorescent	proteins	 in	 erythroid	progenitors	and	mature	neutrophils		-	Tg(gata1:dsRed)	and	Tg(mpx:EGFP)	-	demonstrated	an	abnormal	 accumulation	 of	 HSCs,	 myeloid	 and	 erythroid	 progenitors	 in	 the	 embryo	hematopoietic	 tissue,	 at	 the	 expense	 of	 more	 differentiated	 cells.	 Moreover,	 wnt10b	overexpression	 affects	 the	 migration	 of	 myeloid	 cells	 in	 the	 ALM	 (Anterior	 Lateral	Mesoderm).	Taken	together,	these	results	support	the	notion	of	an	involvement	of	wnt10b	in	vertebrate	 hematopoiesis.	A	 plasmid	 construct	 with	 zebrafish	wnt10b	under	 the	 control	 of	
runx1	 (a	 pivotal	 gene	 in	 definitive	 hematopoiesis)	 promoter	 and	 flanked	 by	 trasposase-responsive	 elements	 has	 been	 generated;	 injection	 of	 this	 plasmid	 in	 zebrafish	 embryos	together	 with	 trasposase	 mRNA	 will	 lead	 to	 the	 generation	 of	 a	 transgenic	 line	 in	 which	
wnt10b	expression	can	be	induced	only	in	definitive	HSCs.	Future	plans	include	the	temporal	control	of	 the	 transgene	expression	 through	 the	 insertion	 in	 the	plasmid	of	a	 lox-P	cassette	flanking	a	STOP	signal	and	the	outcross	of	the	resulting	transgenic	line	with	a	line	expressing	Cre	recombinase	under	the	control	of	hsp70	(heat-shock	protein)	promoter.	This	model	will	
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provide	 the	 chance	 to	 better	 understand	 the	Wnt-mediated	 early	mechanisms	 that	 lead	 to	leukemia	development.	 																								
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ACUTE	MYELOID	LEUKEMIA		Acute	 myeloid	 leukemia	 (AML)	 is	 a	 heterogeneous	 clonal	 disorder	 that	 results	 from	 an	abnormal	expansion	of	uncontrollably	proliferating	myeloid	progenitors	that	 lose	the	ability	to	 differentiate	 (Sykes	 et	 al.,	 2015:	 Estey	 and	 Döhner,	 2006).	 The	 consequence	 of	 this	abnormal	proliferation	is	the	lack	of	differentiated	blood	cells,	leading	to	infection,	bleeding	or	organ	infiltration.	The	incidence	is	greater	in	adults	65	years	of	age	and	older.	Treatment	 in	 younger	 adults	 consists	 of	 two	 phases,	 an	 induction	 therapy	 that	 aims	 to	produce	 complete	 remission,	 and	 a	 post-remission	 therapy,	 in	 order	 to	maintain	 remission	(Estey	 and	 Döhner,	 2006).	 Elderly	 patients	 are	 characterized	 by	 unfavourable	 prognostic	factors,	in	addition	to	their	inability	to	tolerate	cytotoxic	chemotherapy,	making	it	difficult	to	have	a	complete	remission	(Lowenberg	et	al.,	1999).	Different	classifications	of	AML	have	been	proposed:	 the	FAB	(French	–	American	–	British)	classification	(1976)	is	based	on	the	myeloid	lineage	involved	and	the	degree	of	leukemic	cell	differentiation	 (Table	 1)	 (Lowenberg	 et	 al.,	 1999),	 whereas	 the	 more	 recent	 WHO	classification	 (Corradini	 and	 Foà,	 2008)	 looks	 at	 the	 morphologic,	 clinical,	 genetic	 and	molecular	features	of	the	various	disorders.	The	European	LeukemiaNet	(ELN)	(Mrózek	et	al.,	2012)	 and	 the	 National	 Comprehensive	 Cancer	 Network	 (NCCN)	 (NCCN	 Clinical	 Practice	Guidelines	 in	 Oncology,	 2014)	 classifications	 integrate	 genetic	 findings	 with	 treatment	outcome	in	AML,	and	divide	cases	in	prognostic	risk	groups.	Secondary	 AML	 arises	 from	 myelodysplastic	 syndrome	 (MDS)	 and	 myeloproliferative	neoplasms	(MPNs)	or	after	 treatment	with	cytotoxic	chemotherapy,	whereas	 the	etiology	of	
de	 novo	 (or	 primary)	 AML	 remains	 poorly	 understood.	 Several	 risk	 factors	 have	 been	associated	 with	 its	 development,	 such	 as	 benzene	 and	 pesticides	 exposures,	 cigarette	smoking,	 and	 genetic	 disorders	 (Sykes	 et	 al.,	 2015;	 Corradini	 and	 Foà,	 2008;	 Estey	 and	Döhner,	2006).		GENETICS	OF	AML		Both	de	novo	and	secondary	AML	are	characterized	by	chromosomal	abnormalities,	 such	as	deletions	and	translocations		(Deschler	and	Lübbert,	2006).	Many	 chromosomal	 translocations	 have	 been	 associated	 with	 AML,	 more	 than	 the	 known	leukemic	 phenotypes.	 So	 the	 fusion	 proteins	 originating	 from	 these	 rearrangements	 likely	misregulate	 similar	 transcription	 or	 transduction	 pathways	 involved	 in	 the	 normal	
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hematopoietic	development.		Members	of	this	group	of	transcription	factors	are	Core	Binding	Factor	 (CBF),	 retinoic	 acid	 receptor	 alpha	 (RARα),	 and	HOX	 family	 components	 (Kelly	 and	Gilliland,	2002).			
	
	
Table	1.	The	FAB	classification	of	AML	and	associated	genetic	abnormalities		(from	Lowenberg	et	al.,	1999)			CBF	 is	composed	of	a	DNA	binding	component,	named	AML1	(also	known	as	RUNX1)	and	a	second	subunit	(CBFβ)	that	regulates	the	transcriptional	activity	of	AML1.	The	translocations	involving	 CBF	 are	 t(8;21),	 inv(16),	 t(12;21),	 with	 resulting	 fusion	 proteins	 AML1/ETO,	CBFβ/SMMHC,	 and	 TEL/AML1,	 respectively,	 in	 which	 CBF	 transcriptional	 activity	 is	repressed.	 The	 most	 common	 translocation	 involving	 RARα	 produces	 the	 fusion	 protein	PML/RARα.	A	common	 feature	 in	 the	mechanism	of	 transcriptional	 repression	mediated	by	these	 proteins	 is	 the	 aberrant	 recruitment	 of	 the	 nuclear	 corepressor/histone	 deacetylase	
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complex.	 As	 a	 result,	 the	 transcription	 of	 genes	 pivotal	 in	 hematopoietic	 development	 is	blocked	and	therefore	blood	cell	differentiation	is	impaired	(Kelly	and	Gilliland,	2002).	Translocations	involving	HOX	family	members	probably	lead	to	the	constitutive	activation	of	proteins	 which	 activity	 normally	 decreases	 during	 differentiation;	 the	 consequence	 is	 the	abnormal	increase	of	progenitors	at	the	expense	of	mature	blood	cells	(Forrester	et	al.,	2011).		Even	if	these	translocation	events	alter	hematopoietic	development,	they	are	not	sufficient	to	drive	AML.	Several	studies	demonstrated	the	requirement	for	a	second	mutation	to	induce	the	disorder	(Kelly	and	Gilliland,	2002).	Gilliland	and	Griffin	(Gilliland	and	Griffin,	2002)	proposed	a	“2-hit	model”	of	leukemogenesis	(Fig.	1)	and	identified	two	different	classes	of	mutations:	class	I	is	represented	by	mutations	that	 confer	 proliferative	 and	 survival	 advantage	 without	 affecting	 differentiation,	 whereas	class	II	mutations	impair	hematopoietic	differentiation.	AML	develops	when	mutations	from	both	classes	are	present.	AML1/ETO,	CBFβ/SMMHC,	TEL/AML1,	PML/RARα	and	HOX	genes	mutations	are	members	of	class	II.	In	class	I	we	can	find	RAS,	KIT,	and	FLT3	genes,	that	have	a	role	 in	 normal	 hematopoiesis,	 and	 whose	 mutations	 lead	 to	 the	 constitutive	 activation	 of	tyrosine	 kinases	 or	 their	 downstream	 effectors,	 with	 subsequent	 impairment	 of	 cell	proliferation	(Beghini,	2000;	Gilliland	and	Griffin,	2002;	Grimwade	et	al.,	2015).					
		
Fig.	1.	“Two-hit”	model	of	leukemogenesis.	(from	Gilliland	and	Griffin,	2002)	
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Jan	 and	 collaborators	 (Jan	 et	al.,	 2012)	 proposed	 that	 hematopoietic	 stem	 cells	 accumulate	serial	 mutations	 in	 “landscaping	 genes”	 with	 roles	 in	 DNA	 methylation,	 chromatin	modification,	 and	 cohesin	 complex,	 resulting	 in	 the	 formation	 of	 a	 pre-leukemic	hematopoietic	 stem	 cells	 population.	 These	 cells	 remain	 functionally	 normal	 until	 they	acquire	 other	 mutations	 in	 proliferating	 genes:	 these	 additional	 event	 leads	 to	 AML	development	(Sykes	et	al.,	2015).		The	 maintenance	 of	 leukemia	 is	 guaranteed	 by	 the	 presence	 of	 a	 subset	 of	 AML	 cells	characterized	by	 limitless	 self-renewal	 (Leukemia	 stem	cells,	 LSCs),	 a	property	 shared	with	normal	 HSCs	 (Hematopoietic	 Stem	 Cells).	 Since	 these	 features	 make	 LSCs	 potential	therapeutic	targets,	several	studies	focused	on	those	signaling	pathways	whose	control	their	development	(Wang	et	al.,	2010).	One	of	the	strongest	candidates	is	the	Wnt	pathway.			THE	WNT	PATHWAY	IN	DEVELOPMENT,	HEMATOPOIESIS	AND	BLOOD	DISEASES		The	Wnt	pathway	is	highly	evolutionarily	conserved	and	plays	roles	in	several	developmental	processes.	 Its	 genes	 encode	 secreted	 glycoproteins	 that	 interact	 with	membrane	 receptors	(the	Frizzled	family)	activating	different	 intracellular	pathways.	The	canonical	Wnt	pathway	leads	to	beta-catenin	activation:	instead	of	being	degraded,	as	in	the	absence	of	Wnt	ligands,	beta-catenin	 is	 translocated	 in	 the	 nucleus,	 where	 it	 acts	 as	 a	 transcription	 activator.	 This	pathway	 is	highly	 regulated	 through	various	molecules	 that	act	 in	 the	different	 steps	of	 the	cascade,	 interfering	 with	 the	 receptors,	 the	 beta-catenin	 degradation	 complex,	 or	 the	transcriptional	complex	(Mikesch	et	al.,	2007).	The	Wnt	 pathway	 is	 involved	 in	many	 processes	 during	 embryogenesis,	 acting	 on	 cell	 fate	specification,	 cell	 differentiation	 and	 proliferation,	 and	 determination	 of	 dorso-ventral	 and	antero-posterior	axis	 (Hikasa	et	al.,	 2013).	 It	 also	plays	a	pivotal	 role	 in	 the	homeostasis	of	many	 tissues	 and	 organs,	 regulating	 the	 determination	 and	 maintenance	 of	 stem	 cell	compartments.	That	said	it	is	not	surprisingly	that	malignancies	involving	different	organs,	as	heart,	 intestine,	 mammary	 gland,	 and	 CNS	 have	 been	 associated	 with	misregulation	 of	 the	pathway	(Ring	et	al.,	2014).		In	particular,	the	Wnt	signaling	has	a	function	in	the	control	of	hematopoietic	progenitors	and	stem	cells	self-renewal,	thereby	regulating	their	proliferation	(Mikesch	et	al.,	2007).	Congdon	and	coworkers	 (Congdon	et	al.,	 2008)	 found	 that	 the	Wnt	signaling	 is	highly	activated	after	injury	 during	 hematopoietic	 regeneration;	 interestingly,	 the	 regeneration	 process	 is	
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supported	by	bone	marrow	microenvironment	 through	an	 increased	expression	of	 the	Wnt	ligand	WNT10B	(Congdon	et	al.,	2008).		
WNT10B	 is	upregulated	 in	various	malignant	disorders	 (for	a	complete	review	see	Wend	et	
al.,	 2012)	 and	 several	 lines	 of	 evidence	 point	 to	 a	 correlation	 between	 the	 Wnt	 signaling	misregulation	 and	 the	AML	pathogenesis;	 indeed,	many	AML	 cases	 are	 characterized	by	 an	aberrant	expression	of	Wnt	ligands,	that	upregulate	the	signaling	pathway	and	stimulate	LSCs	proliferation	(Mikesch	et	al.,	2007).		Beghini	 and	 colleagues	 (Beghini	 et	 al.,	 2012)	 reported	 an	 overall	 upregulation	 of	 the	Wnt	signaling	in	AML	cells,	with	the	notably	increase	in	the	expression	of	WNT10B	in	AML	patients	bone	marrow	microenvironment,	suggesting	that	the	regenerative	Wnt	signaling	is	altered	in	AML.			ZEBRAFISH	AS	A	MODEL	SYSTEM		Given	 that	 a	 good	 animal	 model	 has	 to	 be	 easy	 and	 cheap	 to	 maintain,	 share	 functional	processes	with	human,	 and	 guarantee	 about	 rapid	 and	 reproducible	 experiments,	 zebrafish	(Danio	 rerio)	 has	 became,	 in	 the	 last	 years,	 fundamental	 in	 developmental	 biology,	pharmacology	and	biomedicine	for	the	study	of	various	diseases.	This	freshwater	teleost	originated	in	the	shallow	waterways	of	the	Indian	subcontinent,	and	is	easy	and	cheap	to	maintain	thanks	to	its	small	size.	More	than	200	eggs	can	be	obtained	from	a	single	mating	event,	 the	 fertilization	 is	external	and	the	embryo	develops	quite	rapidly:	 in	just	24	hours	the	main	organs	are	laid	out	(Fig.	2).	The	embryos	are	transparent	during	their	first	day	of	development,	and	later	pigmentation	can	be	chemically	inhibited,	making	it	easy	to	analyze	 embryogenesis	 and	 organogenesis.	 Pathways	 and	 gene	 functions	 are	 conserved	between	zebrafish	and	the	other	Vertebrates,	and	almost	all	the	genes	associated	with	human	diseases	have	their	homologue	in	zebrafish	(Santoriello	and	Zon,	2012).		Zebrafish	embryos	adsorb	chemicals	through	their	water,	so	they	can	be	used	for	in-vivo	drug	screenings	 characterized	 by	 unbiased/high-throughput	 outcomes	 of	 the	 in-vitro	 systems.	Many	chemicals,	or	different	concentrations	of	one	compound,	can	be	simply	 tested	using	a	multi-well	plate	and	observing	siblings	development	(Garcia	et	al.,	2016).			
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Fig.	 2.	 Zebrafish	 life	 cycle.	On	 the	 left:	 stages	of	 zebrafish	development.	On	 the	 right:	 live	images	 of	 representative	 stages	 (modified	 from	 Allison D’Costa and Iain T. Shepherd, 
2009). 			
Alteration	of	gene	expression	
	Zebrafish	embryos	can	be	easily	injected	with	nucleic	acids	in	order	to	alter	gene	expression.	Gene	overexpression	can	be	performed	by	the	injection	into	the	one-cell	embryo	(zygote)	of	a	specific	 synthetic	 transcript	 (Fig.	 3),	 whereas	 the	 injection	 of	 an	 antisense	 oligonucleotide	(morpholino,	MO)	complementary	 to	a	 target	mRNA	can	block	 its	 splicing	or	 its	 translation	into	protein	(gene	expression	knock-down).	MO	knock-down	and	mRNA	overexpression	can	be	 performed	 individually	 or	 together;	 the	 following	 analysis	 on	 embryo	 development	 at	phenotypic,	 cellular,	 and	 molecular	 level	 provide	 useful	 information	 concerning	 the	involvement	of	the	gene	of	interest	in	a	specific	pathway.					
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Fig.	3.	Zebrafish	embryos	micromanipulation.	A)	Microinjection	apparatus.	B)	Semplified	scheme	 of	 microinjection:	 a	 synthetic	 transcript	 (in	 green)	 is	 injected	 into	 zygotes	 (pink	spheres)	laid	on	a	microscope	glass	(in	blue).		
	
	Recent	studies	pointed	out	the	possibility	to	easily	generate	stable	gene	knock-out	(KO),	using	the	CRISPR-Cas9	 system,	 that	 returns	 targeted	double	 strand	breaks	 followed	by	 the	error-prone	DNA	repair	mechanism	recruitment	that	causes	deletion/insertion	mutations	with	high	frequency	(Garcia	et	al.,	2016).		In	 order	 to	 analyse	 in	 vivo	 cell	 behaviour	 and	 organogenesis,	 as	 well	 as	 the	 effects	 on	development	 caused	 by	 gene	 misregulation,	 many	 transgenic	 lines	 have	 been	 generated	(Kawakami	 et	 al.,	 2007).	 Different	 methods	 exist	 to	 deliver	 a	 specific	 construct	 into	 the	embryo.	 The	 first	 developed	method	was	 the	 plasmid-based	 transgenesis,	 characterized	 by	the	injection	into	the	zygote	of	a	plasmid;	due	to	a	mosaic	expression	of	the	transgene	in	F0,	only	 a	 small	 percentage	 of	 the	 offspring	 receive	 the	 transgene	 (Thermes	 et	 al.,	 2002).	 A	subsequent	approach,	proposed	by	Thermes	and	coworkers	(Thermes	et	al.,	2002)	was	based	on	the	coinjection	of	I-SceI	meganuclease,	a	restriction	enzyme,	with	a	plasmid	that	contains	the	construct	flanked	by	corresponding	restriction	sites;	with	this	method	mosaic	expression	of	 transgene	 in	 F0	 diminished	 and	 germline	 transmission	 rates	 increased,	 improving	transgenesis	efficiency.	Kawakami	 and	 colleagues	 presented	 an	 efficient	 transgenesis	method,	 in	 which	 the	mRNA	coding	 the	 Tol2	 transposase	 is	 coinjected	 in	 the	 zygote	 with	 a	 plasmid	 containing	 a	transposon	construct;	 the	 transgene	 is	expressed	ubiquitously	 through	the	body	 in	F0,	with	very	high	transgenesis	frequency	(Kawakami,	2007).		
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Whatever	 is	 the	method,	 the	 plasmid	 injected	 in	 the	 zygote	 can	 carry	 a	 reporter	 gene	 (for	example	the	green	fluorescent	protein,	GFP)	under	the	control	of	a	specific	tissue	promoter,	allowing	 the	 observation,	 under	 a	 fluorescent	 microscope,	 of	 that	 tissue	 development	 and	cells	behavior.	Furthermore,	 the	zygote	can	be	 injected	with	a	plasmid	 that	contains	a	gene	associated	with	a	human	disease	under	the	control	of	a	promoter	regulating	the	expression	in	the	 organ	 involved	 in	 that	 disease;	 the	 resulting	 transgenic	 line	would	 be	 characterized	 by	stable	overexpression	of	the	wild	type	or	the	mutated	form	of	the	gene	of	interest,	allowing	a	more	detailed	analysis	of	 the	 involvement	of	 such	gene	 in	 the	onset	and	progression	of	 the	disease.				ZEBRAFISH	AND	HUMAN	HEMATOPOIESIS	RESEMBLANCES		Hematopoiesis	 is	 the	 process	 of	 blood	 cellular	 components	 formation	 that	 begins	 during	embryogenesis	 to	 create	 a	 functional	 blood	 system	 and	 continues	 throughout	 adulthood	 to	replenish	it.		This	 process	 shares	 many	 steps	 among	 Vertebrates.	 First	 of	 all,	 there	 are	 two	 phases	 in	hematopoiesis:	the	primitive	wave	and	the	definitive	wave.	The	aim	of	the	primitive	wave	is	to	generate	 non-pluripotent	 progenitors	 that	 give	 rise	 to	 erythrocytes	 and	 macrophages,	 in	order	to	permit	growth	and	survival;	this	wave	is	transient	and	occurs	in	blood	islands	of	the	extra-embryonic	yolk	sac	of	mammals	and	avians	(Fig.	4-step	1)	(Jagannathan	and	Zon,	2013).		Human	definitive	HSCs	(multipotent	cells	 that	give	rise	 to	all	blood	 lineages)	arise	 from	the	ventral	wall	of	the	dorsal	aorta	in	a	region	called	aorta	–	gonad	–	mesonephros	(AGM)	(Fig.	4-step	2),	migrate	 to	 fetal	 liver	and	 finally	 to	 thymus	and	bone	marrow	(Fig.	4-step	3),	where	adult	hematopoiesis	takes	place	(Jagannathan	and	Zon,	2013).	On	 the	 other	 hand,	 zebrafish	 primitive	 hematopoiesis	 (Fig.	 5-yellow	 panel)	 is	 intra-embryonic;	it	occurs	during	the	first	day	of	development	in	the	anterior	(ALM)	and	posterior	(PLM)	lateral	mesoderm.	The	ALM	is	the	site	of	myelopoiesis,	and	gives	rise	to	two	different	types	of	myeloid	cells:	granulocytes,	and	monocytes	and	macrophages	(Chen	and	Zon,	2009).	As	 for	 mammals,	 the	 master	 regulator	 of	 primitive	 myeloid	 cell	 development	 is	 the	transcription	factor	pu.1/spi1	(Jagannathan	and	Zon,	2013).				
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Fig.	 4.	 Comparison	 of	 human	 and	 zebrafish	 hematopoiesis.	 Human	 hematopoiesis:	 1-	embryonic	 hematopoiesis	 takes	 place	 in	 the	 yolk	 sac;	 2-	 during	 definitive	wave	HSCs	 arise	from	 AGM;	 3-	 definitive	 hematopoiesis	 takes	 place	 in	 bone	marrow	 and	 thymus.	 Zebrafish	hematopoiesis:	 1-	 primitive	wave	occurs	 in	 lateral	mesoderm	and	 ICM;	2-	 during	definitive	wave	 HSCs	 arise	 from	 AGM;	 3-	 definitive	 HSCs	 colonize	 thymus	 and	 kidney	 (Images	 from	Baron	et	al,	2012;	Medvinsky	et	al.,	2011;	Kimmel	et	al.,	1995).			The	PLM	cells,	expressing	the	evolutionary	conserved	transcription	factor	gata1	(Jagannathan	and	Zon,	2013),	migrate	medially	to	form	the	intermediate	cell	mass	(ICM)	(Fig.	4-step	1)	and	differentiate	 into	 proerythroblasts	 that	 enter	 the	 circulation	 at	 24	 hours	 post	 fertilization	(hpf)	(Chen	and	Zon,	2009).		From	24	to	36	hpf	erythromyeloid	progenitors,	without	self-renewal	capability,	are	found	in	the	posterior	blood	island	(PBI)	(Fig.	5-pink	panel),	also	known	as	the	caudal	hematopoietic	tissue	(CHT);	these	cells	give	rise	to	erythroid	and	myeloid	cells	during	the	transient	definitive	wave	(Chen	and	Zon,	2009).	Definitive	wave	of	zebrafish	hematopoiesis	(Fig.	5-blue	panel)	originates	in	the	AGM	(Fig.	4-step	 2),	 where	 HSCs	 emerge	 from	 the	 endothelium	 of	 the	 ventral	 wall	 of	 the	 aorta	 and	differentiate	into	progenitors	that	migrate	and	seed	the	CHT,	the	thymus	and	the	pronephros	(Fig.	 4-step	 3),	 where	 they	 proliferate	 in	 order	 to	 expand	 the	 stem	 cell	 niche.	 CHT	
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hematopoiesis	 stops	 at	 6	 days	 post	 fertilization	 (dpf),	 as	 the	 primary	 site	 of	 definitive	hematopoiesis	in	the	adult	is	the	kidney	marrow	(Chen	and	Zon,	2009).		Like	in	mammals,	zebrafish	definitive	hematopoiesis	is	dependent	on	the	transcription	factor	
runx1,	 expressed	 in	HSCs	during	embryogenesis	and	adulthood	(Chen	and	Zon,	2009);	mice	lacking	 runx1	 expression	 lose	 all	 blood	 cell	 lineages	 (Jagannathan	 and	 Zon,	 2013),	 and	zebrafish	 embryos	 injected	 with	 runx1	 morpholino	 display	 defects	 in	 vasculogenesis	 and	primitive	 and	 definitive	 hematopoiesis,	 with	 an	 enlargement	 of	 the	 ICM	 (due	 to	 an	accumulation	 of	 hematopoietic	 progenitors),	 lack	 of	 normal	 circulation,	 and	 reduced	expression	 of	 myb,	 a	 transcription	 factor	 essential	 for	 the	 formation	 of	 definitive	 blood	lineages	(Kalev-Zylinska	et	al.,	2002).				
	
	
	
Fig.	5.		Spatial	and	temporal	representation	of	hematopoiesis	in	the	zebrafish.	Primitive	wave	(yellow)	consists	of	hemangioblasts	that	give	rise	to	myeloid	(M)	and	endothelial	cells	
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(EC)	 in	 the	anterior	 lateral	mesoderm	(ALM),	and	 to	erythroid	 (E)	and	ECs	 in	 the	posterior	lateral	 mesoderm	 (PLM),	 which	 later	 becomes	 the	 intermediate	 cell	 mass	 (ICM).	 In	 the	posterior	 blood	 island	 (PBI),	 the	 erythromyeloid	 progenitors	 (EMPs)	 give	 rise	 to	 erythroid	and	myeloid	 cells	 in	 a	 transient	wave	 (pink).	 The	 definitive	wave	 (blue),	 that	 contains	 the	long-term	 self-renewing	 hematopoietic	 stem	 cells	 (HSCs),	 originates	 in	 the	 aorta-gonad-mesonephros	 (AGM).	 ECs	 and	 hematopoietic	 progenitor	 cells	 (P)	 that	 originate	 in	 the	AGM	migrate	 to	and	colonize	other	sites	of	definitive	hematopoiesis.	 In	 the	caudal	hematopoietic	tissue	(CHT)	HSCs	proliferate	and	give	rise	to	erythroid,	myeloid	and	thromboid	(T)	lineages.	Kidney	marrow	contains	all	the	different	blood	lineages,	including	the	lymphoid	B	cell	(L(B))	lineage.	 The	 common	 lymphoid	 progenitor	 (CLP)	mature	 into	 lymphoid	 cells	 (L(T))	 in	 the	thymus.	The	locations	of	different	sites	of	hematopoiesis	are	depicted	in	a	24	hpf		and	a	72	hpf	embryo	(from	Chen	and	Zon,	2009).			ZEBRAFISH	AS	A	MODEL	FOR	BLOOD	DISORDERS		The	 evolutionary	 conservation	 of	 transcription	 factors	 and	 their	 role	 in	 hematopoiesis	between	zebrafish	and	mammals	makes	of	zebrafish	an	excellent	model	to	study	the	pathways	involved	 in	 blood	 system	 development	 and	 their	 misregulation	 in	 blood	 diseases.	 Several	transgenic	lines,	characterized	by	the	expression	of	fluorescent	proteins	in	different	blood	cell	types,	 have	been	 generated,	 such	 as	 spi1:EGFP	 for	myeloid	progenitors	 (Ward	et	al.,	 2003),	
mpx:GFP	for	neutrophils	(Renshaw	et	al.,	2006),	and	gata1:DsRed	for	erythroblasts	(Traver	et	
al.,	2003).		In	 addition,	 zebrafish	 has	 been	 used	 to	 mimic	 human	 leukemia	 by	 transient	 or	 stable	overexpression	 and	 knock-down	 of	 genes	 involved	 in	 its	 pathogenesis.	 The	 first	 transgenic	zebrafish	generated	to	model	leukemia	expressed	the	mouse	Myc	gene	(involved	in	definitive	hematopoiesis)	under	the	control	of	the	lymphoid	marker	Rag2;	this	transgenic	line	displayed	the	typical	features	of	T-cell	acute	lymphoblastic	leukemia	(T-ALL)	(Jing	and	Zon,	2011).		AML	has	also	been	modeled	in	zebrafish	(Jing	and	Zon,	2011).	A	transgenic	line	expressing	the	fusion	 gene	AML/ETO	under	 the	 control	 of	hsp70	 promoter	 has	 been	 generated.	 AML/ETO	overexpression	 led	 to	 the	misregulation	of	 the	myeloid-erythroid	balance	 at	 the	 expense	of	the	 erythroid	 cell	 lineage	 (Payne	 and	 Look,	 2009).	 	 Another	 model	 involved	 the	 human	oncogene	MOZ/TIF2,	expressed	in	this	AML-zebrafish	under	the	control	of	spi1,	which	led	to	the	accumulation	of	myeloid	cells	in	the	kidney	(Rasighaemi	et	al.,	2015).		
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Forrester	 and	 colleagues	 (Forrester	 et	 al.,	 2011)	 reported	 the	 generation	 of	 a	 transgenic	zebrafish	 line	 expressing	 the	 human	 fusion	 gene	 NUP98-HOXA9,	 normally	 associated	 with	poor	prognosis	in	AML,	under	the	control	of	the	spi1	promoter	in	a	Cre/lox	inducible	fashion;	since	Cre	recombinase	is	expressed	only	following	the	activation	of	Hsp70,	overexpression	of	the	 fusion	 gene	 is	 temporally	 and	 spatially	 regulated.	 Transgenic	 fish	 displayed	 aberrant	hematopoiesis	 and	 developed	 a	myeloproliferative	 neoplasm	 in	 adulthood	 (Forrester	 et	al.,	2011).		Given	the	similarities	between	human	and	zebrafish	hematopoiesis,	together	with	the	above	mentioned	 unique	 features	 of	 zebrafish,	 the	 aim	 of	 this	 study	was	 to	 analyze	 the	 effects	 of	
wnt10b	overexpression	 on	 hematopoiesis	 and	 AML	 pathogenesis	 employing	 zebrafish	 as	 a	model.				WNT	PATHWAY	AND	wnt10b	IN	ZEBRAFISH		The	Wnt	pathway	in	zebrafish	regulates	different	processes	depending	on	the	moment	of	its	activation.	Maternal	Wnts,	present	during	the	early	steps	of	development,	are	essential	for	the	formation	of	dorsal	structures,	and	their	 inactivation	 leads	to	 the	dramatic	ventralization	of	the	 embryos,	 that	 display	 a	 reduced	 or	 absent	 head	 (Lu	 et	 al.,	 2011;	 Beghini	 et	 al.,	 2012).	Conversely,	 activation	 of	 the	 Wnt	 pathway	 after	 the	 mid-blastula	 transition	 stage	 (MBT),	when	the	zygotic	genome	starts	to	be	expressed,	has	a	role	in	determining	the	posteriormost	structures	 of	 the	 embryo,	 and	 its	 aberrant	 activation	 causes	posteriorized	phenotypes,	 that	miss	the	anterior	regions	of	the	head	(van	de	Water	et	al.,	2001;	Beghini	et	al.,	2012).			Zebrafish	wnt10b	has	been	described	for	the	first	time	by	Lekven	and	colleagues	(Lekven	et	
al.,	2003),	and	comparison	of	the	protein	sequence	among	Vertebrates	showed	a	high	degree	of	 conservation.	 Gene	 expression	 analysis	 performed	 through	 in-situ	 hybridization	 during	embryonic	 development	 showed	 that	 wnt10b	 expression	 is	 present	 in	 the	 midbrain	 –	hindbrain	boundary	(MHB),	in	the	epiphysis,	cerebellum	and	rhombomeres,	overlapping	the	expression	 of	 another	member	 of	 the	 family,	wnt1.	 Indeed,	 functional	 experiments	 showed	that	 the	 two	 genes	 are	 partially	 redundant	 in	 regulating	 the	 expression	 of	 those	 genes	involved	in	the	maintenance	of	the	MHB	(Lekven	et	al.,	2003).				
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AIM	OF	THE	STUDY		
WNT10B	 	upregulation	 in	various	cancer	disorders	 (Wend	et	al.,	2012),	particularly	 in	bone	marrow	microenviroment	of	AML	patients	(Beghini	et	al.,	2012),	and	its	role	in	hematopoietic	regeneration	(Congdon	et	al.,2008),	led	us	to	deepen	our	knowledge	about	its	role	in	normal	and	malignant	hematopoiesis.	Thanks	to	its	unique	features,	we	decided	to	use	zebrafish	as	a	model.	Given	the	high	degree	of	similarity	between	the	human	and	zebrafish	proteins	(73%		aminoacid	identity)	(Lekven	et	al.,	2003),	zebrafish	wnt10b	was	used.		At	 first	 we	 asked	 if	 zebrafish	 represented	 a	 feasible	 model	 for	 the	 study;	 to	 answer	 this	question,	 the	 functional	 analysis	was	 performed	 by	means	 of	 transient	 overexpression;	 the	effects	of	the	forced	wnt10b	upregulation	was	investigated	using	in-situ	hybridization	or	live	imaging	 of	 transgenic	 lines	 for	 genes	 that	 are	markers	 of	 blood	 cell	 development	 (scl,	pu.1,	
mpx,	gata1).	Our	results	show	that	transient	wnt10b	overexpression	affects	zebrafish	hematopoiesis,	thus	we	planned	to	generate	a	stable	zebrafish	transgenic	line	expressing,	in	a	Cre	–	lox	inducible	fashion,	wnt10b	under	the	control	of	the	runx1	promoter,	leading	to	a	temporally	and	spatially	restricted	overexpression	of	the	gene	of	 interest	 in	the	embryos	and	adult	 fish	for	following	analyses.		
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ZEBRAFISH	MAINTEINANCE		Different	zebrafish	strains	were	used	for	experiments:	- AB	wt	strain	- Tg(mpx:EGFP)	(Renshaw	et	al.,	2006)	- Tg(gata1:DsRed)		(Traver	et	al.,	2003)	Adult	fishes	were	maintained	at	28°C	and	on	a	14	h	light/10	h	dark	cycle.	Embryos	were	obtained	through	natural	matings,	raised	at	28°C	in	Fish	Water	with	PTU	(1-phenyl-2-thiourea)	to	avoid	pigmentation,	and	staged	as	described	(Kimmel	et	al.,	1995).		The	Animal	Welfare	Act	(AWA)	covers	fish	that	are	able	to	feed	on	their	own	and	no	longer	are	reliant	on	the	yolk	sac.	Agreeing	to	"The	Zebrafish	Book",	the	embryos	use	up	their	yolk	sacs	in	about	4	days,	after	which	they	must	feed,	until	reaching	nutritional	independence	at	8	days	post	 fertilization	(dpf).	According	 to	 the	general	guidelines	of	 the	“University	of	Maine	Institutional	 Animal	 Care	 and	 Use	 Committee	 Guidelines	 for	 Use	 of	 Zebrafish	 in	 Research,	Teaching,	and	Testing”,	a	IACUC	protocol	for	studies	using	zebrafish	embryos	younger	than	4	dpf	is	not	required.	Also	important,	the	same	Guidelines	state	that	early	stages	(4–7	dpf)	do	not	feel	pain	or	distress.	The	higher	percentage	of	the	animals	employed	in	this	Research	will	be	embryos	same	age	or	younger	than	4	dpf.	Our	animal	facility	strictly	adheres	to	the	relevant		Italian		laws,		rules		and		regulations		(D.to		L.vo		116/92),	as	also	confirmed	by	the	Autorizzazione	Comunale	of	the	city	of	Milan	(D.Lvo	27.1.1992	n°116,	art.10).		RT-PCR		Given	the	similarity	between	human	and	zebrafish	wnt10b	sequence	and,	probably,	function,	we	decided	to	make	use	of	the	zebrafish	gene	for	all	the	experiments.	Total	 RNA	 from	 1-cell	 stage	 to	 4dpf	 embryos	 was	 extracted	 with	 ReliaPrepTM	 RNA	 Tissue	Miniprep	 System	 (Promega)	 and	 reverse	 transcribed	 with	 the	 ImProm-IITM	 Reverse	Transcriptase	Kit	(Promega),	according	to	manufacturers’	instructions.	Subsequent	PCR	was	performed	using	the	following	primers:	zf_wnt10b_START			 GGGCCCGGGCCGCCATGGAGTTACCCCACAGACAG	 	zf_wnt10b_STOP				 GGTCCCGGGCCTACTTGCACACATTAACCCACTC 
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The	 zf_wnt10b_START/	 zf_wnt10b_STOP	 amplicon	 (1282	 bp)	 has	 been	 gel	 extracted	 with	Wizard®	 SV	 Gel	 and	 PCR	 Clean-Up	 System	 (Promega)	 and	 cloned	 in	 pCMV-SC	 vector	(Strataclone).			SITE	DIRECTED	MUTAGENESIS		Mutagenesis	was	performed	according	to	Zheng	et	al.	(2004)	on	pCMV-SC_wnt10b	to	remove	the	SacI	restriction	site	from	wnt10b	sequence.	The	following	primers	were	used:		FF_wnt10bMut:				 AGGAGAGAACACACCTGAGCTTAGCTCGCTCCACGGCAGCCTT 		RR_wnt10bMut:		 AAGGCTGCCGTGGAGCGAGCTAAGCTCAGGTGTGTTCTCTCCT			Following	 plasmid	 denaturation,	 annealing	 with	 mutagenic	 primers	 and	 extension,	 the	product	 was	 digested	 with	DpnI,	 that	 cleaving	 at	 methylated	 sites	 destroyed	 the	 template	plasmid.	The	PCR	product	was	transformed	in	competent	cells.			EXPRESSION	ANALYSIS		RT-PCR	was	performed	on	embryos	at	28hpf	and	3dpf	or	on	 their	 tails,	using	all	 the	above	mentioned	primers.		The	579	bp	products	were	run	on	1%	agarose	gel.				mRNA	MICROINJECTION		Capped	wnt10b	mRNA	was	 synthesized	 from	zf_wnt10b_START/	 zf_wnt10b_STOP	 	 amplicon	with	mMESSAGE	mMACHINE®	T3	Transcription	Kit	(TermoFischer).	Embryos	microinjection	at	 one-cell	 stage	was	 performed	with	 FemtoJet	 precision	 pressurized	 injector	 (Eppendorf).	
wnt10b	 mRNA	 (1000	 pg/embryo)	 or	 control	 EGFP/DsRed	 mRNA(1000	 pg/embryo)	 were	injected	together	with	the	dye	tracer	rhodamine	dextran	(Invitrogen).	
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In	situ	HYBRIDIZATION		Whole	 mount	 in	 situ	 hybridization	 was	 carried	 out	 as	 previously	 described	 (Thisse	 et	 a.l,	1993)	 on	 embryos	 fixed	 overnight	 in	 4%	 paraformaldehyde/PBS,	 then	 rinsed	 with	 PBS-Tween,	dehydrated	in	100%	methanol	and	stored	at	-20°C	until	processed	for	WISH	(Jowett	and	Lettice,	1994).	Antisense	riboprobes	for	wnt10b,	pu.1	(Lieschke	et	al.,	2002)	and	scl	(Liao	
et	al.,	1998)	were	used.					
o-DIANISIDINE	staining		Zebrafish	 embryos	 at	 3dpf	 were	 stained	 for	 15	 min	 in	 the	 dark	 in	 o-dianisidine	 staining	solution,	 as	 previously	 described	 (Detrich	et	al.,	 1995).	 Stained	 embryos	were	 cleared	with	benzyl	benzoate/benzyl	alcohol	(2∶1,	vol/vol).				IMAGING	
	
In	 situ	 hybridization	 and	 o-dianisidine-stained	 embryos	 were	 imaged	 by	 Digital	 Camera	DFC310	FX	(Leica)	and	software	LAS	(Leica	Application	Suite)	on	MZ	10F	microscope	(Leica).	Live	 imaging	 of	 transgenic	 embryos	 was	 carried	 out	 using	 Axiovert	 200M	 (Zeiss).	 To	determine	 the	 number	 of	 neutrophils	 in	 the	 mpx:GFP	 transgenics	 each	 embryo	 was	photographed	 on	 4-5	 different	 focal	 planes,	 then	 the	 pictures	 were	 assembled	 in	 a	 single	image	on	which	the	cell	count	was	performed	using	the	ImageJ	1.47	software.				STATISTICAL	ANALYSIS	
χ2	 test	 was	 used	 to	 test	 the	 significance	 of	 the	 differences	 in	 in-situ	 hybridization	 signals	between	control	and	wnt10b-injected	embryos.				
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wnt10b	EXPRESSION	ANALYSIS		In	 order	 to	 deepen	 our	 knowledge	 concerning	 wnt10b	 expression	 during	 zebrafish	development,	we	performed	RT-PCR	on	24	and	72	hpf	(hours	post	fertilization)	embryos	total	RNA.	The	result	shows	the	presence	of	the	transcript	during	these	stages	of	development	(Fig.	6).	Whole	mount	 in-situ	hybridization	 results	 by	 Lekven	 and	 co-workers	 (Lekven	 et	 al.,	2003)	revealed	the	expression	of	the	gene	at	the	level	of	the	midbrain-hindbrain	boundary	(MHB)	at	the	5-somite	stage;	at	24	hpf	the	transcript	is	present	in	the	epiphysis,	dorsal	midline	of	the	optic	tectum,	the	anterior	half	of	the	MHB	constriction,	and	in	all	rhombomeres. We	asked	whether	wnt10b	was	expressed	only	 in	 these	 regions	or	 if	 its	 transcript	 could	be	present	in	more	posterior	hematopoietic	regions,	like	the	Caudal	Hematopoietic	Tissue	(CHT). For	 this	 reason	we	 isolated	 the	 tails	 from	 embryos	 at	 24	 and	 72	 hpf	 and	 searched	 for	 the	presence	of	the	transcript	through	RT-PCR;	the	mRNA,	not	detectable	by	in-situ	hybridization,	is	present	in	the	tail	region	of	24	an	72	hpf	embryos	(Fig.	6).				
wnt10b	OVEREXPRESSION	EFFECTS	ON	EARLY	DEVELOPMENT			
wnt10b	 in-vitro	 synthesized	 transcript	was	 injected	 in	 zebrafish	 eggs	 at	 the	 1-cell	 stage,	 in	order	to	distribute	the	mRNA	in	all	cells	of	the	developing	embryo.	The	optimal	concentration	of	 mRNA	 was	 evaluated	 performing	 various	 injections	 with	 different	 concentrations	 and	observing	the	resulting	phenotype	and	counting	the	number	of	dead	embryos.	One-thousand	pg/embryo	of	mRNA	was	chosen	as	the	optimal	concentration	as	its	injection	causes	the	death	of	about	5%	of	the	embryos	compared	with	control	embryos	injected	with	Green	Fluorescent	Protein	(GFP)	mRNA	(that	has	no	effects	on	development),	and	phenotypic	alterations	in	30%	of	the	embryos;	the	remaining	siblings,	which	showed	normal	development	at	a	first	glance,	were	 employed	 to	 analyse	 cell	 migration,	 tissues	 formation,	 and	 organ	 development,	 in	comparison	to	controls.		Embryos	 injected	 with	 wnt10b	 mRNA	 showed	 alterations	 in	 the	 development	 of	 the	dorso/ventral	 axis	 and	 hematopoietic	 system.	 At	 24	 hpf,	 compared	 with	 control	 embryos,	they	displayed	the	expansion	of	the	caudalmost	tissues,	and	lack	or	reduced	development	of	the	head	and	the	tail.		
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At	72	hpf,	axis	development	alteration	is	evident	and	reflects	the	timing	of	the	upregulation	of	the	Wnt	pathway.	 In	control	embryos	we	saw	a	straight	and	extended	body	axis,	with	head	and	 tail	 at	 the	 extremities	 (Fig.	 7A-D).	 Twenty	%	of	 the	 embryos	 injected	with	 the	wnt10b	transcript	were	 characterized	by	 a	 larger	head,	 absence	of	 one	or	both	 eyes,	 and	absent	or	reduced	 tail	 (Fig.	 7C),	 typical	 features	 of	 dorsalization,	 that	 occur	when	maternal	Wnts	 are	overexpressed.	Ten	%	of	 the	 embryos	 showed	 smaller	heads,	 and	enlarged	 tails	 (Fig.7B-E);	these	alterations	mirror	the	upregulation	of	the	zygotic	Wnt	signaling.				
wnt10b	OVEREXPRESSION	EFFECTS	ON	BLOOD	CIRCULATION		
	Embryonic	blood	circulation	was	in-vivo	analysed	under	a	stereomicroscope.		The	 caudal	 hematopoietic	 tissues	 of	 injected	 embryos,	 analysed	 at	 120	 hpf,	 showed	accumulation	of	cells,	that	often	produced	alteration	or	block	of	blood	circulation.		Thirty	 %	 of	 wnt10b-injected	 embryos	 was	 characterized	 by	 the	 typical	 severe	 axes	aberrations	reported	above,	making	it	impossible	to	analyse	blood	circulation	and	compare	it	to	 control	 embryos;	 23%	 of	 the	 injected	 embryos	 displayed	 the	 decrease	 in	 blood	 flow	velocity	compared	to	control	embryos,	and	in	5%	the	blood	cells	were	motionless.			
	
wnt10b	OVEREXPRESSION	ALTERS	THE	EXPRESSION	PATTERN	OF	scl	
	In	order	to	analyse	the	effects	of	wnt10b	overexpression	on	different	blood	cell	populations,	
in-situ	hybridization	 were	 performed	 using	 various	 hematopoietic	 markers	 probes.	 All	 the	analyses	were	performed	exclusively	on	those	wnt10b	mRNA-injected	embryos	displaying	the	general	 body	 architecture	 comparable	 to	 controls,	 in	 order	 to	 avoid	 any	 bias	 due	 to	malformations.	
scl	 is	 expressed	 in	 the	 Anterior	 (ALM)	 and	 the	 Posterior	 (PLM)	 Lateral	 Mesoderm	 during	somitogenesis,	then	marks	posterior	progenitors	that	migrate	towards	the	midline	to	form	the	ICM	(Gering	et	al.,	1998),	and	is	present	until	30	hpf	in	the	PBI	(Fig.	8A).			Analysis	 of	 progenitor	 populations	 in	 the	 PBI	 at	 28	 hpf	 (Fig.	 8B-C)	 showed	 that	 wnt10b	overexpression	 caused	 an	 expansion	 of	 the	 number	 of	 these	 cells	 in	 70%	 of	 the	 embryos	injected	with	the	transcript	(n=62),	compared	to	controls	(n=	34).	χ2	test	confirmed	that	the	result	was	extremely	significant	(p<0.05).		
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wnt10b	OVEREXPRESSION	ALTERS	THE	EXPRESSION	PATTERN	OF	pu.1	
	Myeloid	 progenitors	 were	 examined	 by	 means	 of	 pu.1	 expression	 at	 different	 stages	 of	development,	during	somitogenesis	and	at	28	hpf.	Control	embryos	showed	 the	normal	expression	pattern	of	pu.1	during	somitogenesis:	 from	14	hpf	(12-somite	stage),	myeloid	progenitors	are	 localized	mostly	 in	two	lateral	clusters	 in	the	ALM	(Fig.	9B);	at	15-somite	stage	these	cells	migrate	toward	the	centre	(Fig.	9E).		Embryos	injected	with	wnt10b	transcript	are	characterized	by	the	anomalous	dispersion	and	the	premature	migration	of	myeloid	progenitors	in	the	ALM	(Fig.	9H-I).		From	16	hpf	myeloid	progenitors	migrate	laterally	and	spread	into	the	yolk	sac	(Davidson	and	Zon,	2004).	In	control	embryos	at	28	hpf,	the	expression	of	pu.1	was	still	present	in	the	yolk	sac	(Fig.	10A),	and	myeloid	progenitors	were	also	found	in	the	ICM	and	the	PBI	until	30	hpf	(Fig.	10A).		Injection	of	wnt10b	mRNA	led	to	the	expansion	of	the	myeloid	cell	population,	in	the	ALM	and	in	the	PBI,	as	shown	in	Fig.	10B-C.		This	expansion	occured	in	54%	of	embryos	injected	with	the	wnt10b	transcript	(n=114)	compared	to	controls	(n=66).	χ2	test	confirmed	that	the	result	was	extremely	significant	(p<0.05).					
wnt10b	OVEREXPRESSION	AFFECTS	ERYTHROID	PROGENITOR	NUMBER		The	transgenic	line	Tg(gata1:DsRed)	was	used	to	better	analyse	the	onset	of	circulation,	since	embryos	 are	 characterized	 by	 the	 expression	 of	 the	 red	 fluorescent	 protein	 (DsRed)	 in	erythroid	progenitors	(Traver	et	al.,	2003).	Thirty	%	of	wnt10b-injected	embryos	(n=58)	at	28	hpf	showed	an	increase	in	the	number	of	gata1	positive	cells	 localized	in	the	PBI	(Fig.	11C),	compared	 to	 controls	 (n=41)	 (Fig.	 11B).	 χ2	 test	 confirmed	 that	 the	 result	 was	 significant	(p<0.05).				
wnt10b	OVEREXPRESSION	ALTERS	THE	NUMBER	OF	NEUTROPHILS	
	Analysis	 of	 differentiated	 myeloid	 population	 was	 performed	 at	 48	 hpf	 through	 in-vivo	observation	 of	 transgenic	 mpx:GFP	 embryos,	 characterized	 by	 expression	 of	 the	 GFP	 in	neutrophils	(Renshaw	et	al.,	2006).		
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Fifty-two	%	of	embryos	injected	with	wnt10b	transcript	(n=18),	compared	to	controls	(n=10)	(Fig.	12A),	shows	a	reduction	in	the	number	of	neutrophils	(Fig.	12B).	Image	data	were	further	analysed	through	CellProfiler	2.1.1	software,	and	the	reduction	in	the	number	of	neutrophils	in	wnt10b-injected	embryos	was	also	statistically	confirmed	(Fig.	12C).				
	
	
wnt10b	 OVEREXPRESSION	 DOES	 NOT	 DISPLAY	 MACROSCOPIC	 EFFECTS	 ON	 MATURE	ERYTHROCYTES	NUMBER	
	Mature	red	blood	cells	were	analysed	through	o-dianisidine	staining	at	72	and	120	hpf.	
Wnt10b	overexpression	 did	 not	 change	 the	 number	 or	 distribution	 of	mature	 erythrocytes	(Fig.	13).				GENERATION	OF	THE	PLASMID	CONSTRUCT	FOR	ZEBRAFISH	ZYGOTE	TRANSGENESIS	
	To	analyse	the	effects	of	wnt10b	overexpression	in	zebrafish	myeloid	cells	in	a	stable	fashion,	we	decided	 to	generate	a	 transgenic	 line	 in	which	wnt10b	is	under	 the	control	of	 the	runx1	promoter.	The	pBluescript	II	SK	plasmid,	containing	the	runx1P2	zebrafish	promoter	driving	the	 expression	 of	 the	 EGFP	 (pBluescript	 II	 SK_runx1P2_EGFP),	 was	 kindly	 donated	 by	professor	 Crosier	 (Lam	 et	 al.,	 2009).	 The	 EGFP	 coding	 sequence	 was	 removed	 from	 the	pBluescript	 II	 SK_runx1P2_EGFP	 by	 digestion	 with	 BamHI	 and	 XhoI	 restriction	 enzymes	(pBluescript	II	SK_runx1P2,	Fig.	14A).	XhoI	and	SacI	restriction	sites	of	pCMV-SC_wnt10b	were	removed	by	PCR-based	Site	Directed	Mutagenesis,	and	the	wnt10b	coding	sequence	with	the	downstream	polyA	region	was	amplified	by	PCR	using	forward	and	reverse	primers	with	BglII	and	 XhoI	 restriction	 sites	 at	 their	 5’	 ends,	 respectively	 (Fig.	 14B).	 The	 amplicon	 was	 then	digested	with	BglII	and	XhoI	restriction	enzymes	(Fig.	14C)	and	cloned	into	the	pBluescipt	II	SK_runx1P2	plasmid	digested	with	BamHI	(BglII	compatible)	and	XhoI	 restriction	sites	 (FIG.	14D).		pGEM-Teasy	was	 linearized	with	 SalI	 (Fig.	 15B)	 and	 ligated	 to	 pT2AL200R150G	 linearized	with	XhoI	(Fig.	15A).	A	PCR	with	T3	and	SP6	primers	was	performed	directly	on	the	ligation	reaction	 (Fig.	 15C),	 resulting	 in	 the	 L200	 fragment	with	SacI	 restriction	 sites	 at	 both	 ends.	L200	 sequence	 was	 digested	 with	 SacI	 and	 ligated	 with	 the	 pBluescript	 II	SK_runx1P2_wnt10b+polyA	linearized	with	SacI	(Fig.	15C-D).		The	R150	sequence	was	excised	
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from	 pT2AL200R150G	 by	 XhoI	 and	 KpnI	 digestion	 and	 ligated	 into	 pBluescript	 II	SK_runx1P2_wnt10b+polyA_L200	digested	with	same	restriction	enzymes	(Fig.	15E-F).	The	 final	 plasmid	 pBluescript	 II	 SK_runx1P2_wnt10b+polyA_L200_R150	 is	 ready	 to	 be	coinjected	 in	 the	 zygote	 with	 the	 transposase	 synthetic	 mRNA	 in	 order	 to	 increase	 the	efficiency	of	the	transgenesis	process	(Kawakami,	2007).																	 	
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Fig.	 6.	 Expression	 profile	 of	 zebrafish	 wnt10b.	 RT-PCR	 was	 performed	 at	 different	developmental	stages	(28hpf	and	3dpf)	and	in	tails	isolated	from	28	hpf	and	3dpf	embryos.	All	samples	 analysed	 are	 positive	 for	wnt10b	expression,	 as	 confirmed	 by	 the	 579	 bp	 specific	amplicon.											
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Fig.	 7.	 wnt10b	 overexpression	 effects	 on	 body	 axis	 development.	 A	 and	 D)	 Control	embryos	at	3	and	4	dpf.	B,	C,	E)	wnt10b-injected	embryos	show	ventral	tissues	expansion	and	absence	of	anteriormost	part	of	the	head	(B),	dorsalization	(C)	and	hypodevelopment	of	the	cephalic	region	also	 in	presence	of	a	straight	body	axis	(E).	All	 lateral	views,	anterior	to	the	left.	Scale	bar	corresponds	to	500	µm	in	A	and	E,	600	µm	in	D,	250	µm	in	B	and	C.	
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Fig.	 8.	 wnt10b	 overexpression	 alters	 the	 expression	 pattern	 of	 scl.	 A	 and	 B)	 In-situ	hybridization	 for	 scl	 on	28	hpf	 embryos	 injected	with	 control	 (A)	 or	wnt10b	 (B)	 transcript.	Arrowheads	 in	 B	 show	 the	 increase	 of	 hematopoietic	 stem	 cells	 compared	 to	 A	 (asterisk).	Scale	 bar	 100	µm.	 A’	 and	 B’	 are	magnifications;	 scale	 bar	 50	µm.	C)	 PBI	magnifications	 of	control	and	wnt10b-injected	embryos.	Lateral	views,	anterior	to	the	left.			
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Fig.	 9.	 wnt10b	 overexpression	 alters	 the	 expression	 pattern	 of	 pu.1	 during	
somitogenesis.	 A)	 Scheme	 representing	 selected	 somitogenesis	 stages.	 B-I’)	 In-situ	hybridization	for	pu.1	in	embryos	injected	with	control	(B-E’)	or	wnt10b	(F-I’)	mRNA.	Frontal	(B-E	and	F-I)	and	lateral	(B’-E’	and	F’-I’)	views,	anterior	to	the	top.	Scale	bar	300	µm.			
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Fig.	 10.	wnt10b	 overexpression	alters	 the	 expression	pattern	of	pu.1.	 A	 and	B)	 In-situ	hybridization	for	pu.1	on	28	hpf	embryos	injected	with	control	(A)	or	wnt10b	(B)	transcript.	Arrowhead	 in	B	 shows	 the	 increase	of	myeloid	progenitors	 compared	 to	A	 (asterisk).	 Scale	bar	100	µm.	A’	and	B’	are	magnifications;	scale	bar	50	µm.	C)	PBI	magnifications	of	control	and	wnt10b-injected	embryos.	Lateral	views,	anterior	to	the	le	
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Fig.	11.	wnt10b	overexpression	increase	the	number	of	erythromyeloid	progenitors.		
A)	 Schematic	 representation	 of	 a	 28hpf	 embryo	with	 PBI	 evidenced	 in	 red.	B	 and	 C)	 Live	imaging	of	28	hpf	 transgenic	gata1:DsRed	embryos	PBI.	 	wnt10b-injected	embryos	show	an	increase	 of	 erythroid	 progenitors	 compared	 to	 controls.	 Scale	 bar	 125	 µm.	 Lateral	 views,	anterior	to	the	left.						
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Fig.	12.	wnt10b	overexpression	alters	the	number	of	neutrophils.	
A	 and	 B)	 In	 vivo	 imaging	 of	 mpx:GFP	 embryos	 at	 48hpf.	 Green	 fluorescent	 neutrophils	decrease	in	wnt10b-injected	embryo	(B)	compared	to	control	(A).	Scale	bare	300	µm.	Lateral	views,	anterior	to	the	left.		
C)	 Statistical	 analysis	 performed	 on	 18	 wnt10b-injected	 and	 11	 control	 embryos.	 Results	confirm	the	reduction	in	the	number	of	neutrophils	of	wnt10b-injected	embryos	compared	to	controls.	**<0.01	with	Student’s	t-test.										
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Fig.	 13.	 	 o-dianisidine	 staining	 of	 3dpf	 embryos.	 Embryos	 injected	with	wnt10b	 mRNA	(C,D)	do	not	 show	differences	 in	 the	number	of	 erythrocytes	 compared	 to	 control	 embryos	(A,B).	Scale	bar	150	µm.	Ventral	views,	anterior	to	the	top.		
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Fig.	 14.	 Schematic	 representation	 of	 the	 generation	 of	 pBluescript	 II	
SK_runx1P2_wnt10b.	 A)	 BamHI	 and	 XhoI	 digestion	 of	 pBluescript	 II	 SK_runx1P2.	 B)	 PCR	starting	from	pCMV_SC_wnt10b	with	primers	with	BglII	and	XhoI	consensus	sequences	at	the	extremities.	C)	PCR	digestion	with	BglII	and	XhoI.	D)	Ligation	and	formation	of	final	plasmid.	
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Fig.	 15.	 	 Generation	 of	 pBluescript	 II	 SK_runx1P2_wnt10b_L200_R150.	 A)	 XhoI	linearization	 of	 pT2AL200R150G.	B)	 SalI	 linearization	 of	 pGEM-T	 easy.	C)	 T3/SP6	 PCR	 on	resulting	 ligation.	D)	 SacI	 digestion	 of	 PCR	 and	 pBluescript	 II	 SK_runx1P2_wnt10b,	 ligation	and	 formation	 of	 	 pBluescript	 II	 SK_runx1P2_wnt10b_L200.	 E)	 XhoI	 and	 KpnI	 digestion	 of	pBluescript	 II	 SK_runx1P2_wnt10b_L200	 and	 pT2AL200R150G.	 F)	 Final	 plasmid	 resulting	from	ligation.																													
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The	aim	of	this	study	was	to	elucidate	the	role	of	WNT10B	as	a	leukemia	driver	in	a	zebrafish	model,	exploring	its	role	in	normal	and	misregulated	zebrafish	hematopoiesis.		Human	 and	 zebrafish	 WNT10B	 aminoacidic	 sequences	 are	 highly	 similar;	 furthermore,	
WNT10B	maps	 in	 close	 proximity	 to	WNT1,	 and	 this	 synthenic	 organization	 is	 maintained	among	Vertebrates	(Lekven	et	al.,	2003).	These	indications	are	suggestive	of	an	evolutionary	conserved	 function	 between	 zebrafish	 and	 human.	 WNT10B	 is	 up-regulated	 in	 various	malignant	disorders	(for	a	complete	review	see	Wend	et	al.,	2012),	supporting	a	role	for	this	gene	 in	carcinogenesis.	 Interestingly,	 the	WNT1-WNT10B	cluster	expression	is	modulated	 in	human	breast	cancer	(Qurrat-ul-Ain	et	al.,	2011).		According	to	the	in-situ	hybridization	analyses	previously	performed	(Lekven	et	al.,	2003;	Lu	
et	al.,	 2011),	 zebrafish	wnt10b	 is	 expressed	 starting	 from	 the	1-cell	 stage,	when	 the	 zygotic	genome	is	still	silent,	proving	the	maternal	origin	of	the	transcript;	at	24hpf,	when	the	zygotic	DNA	is	already	activated,	 its	expression	is	restricted	to	discrete	brain	regions	(Lekven	et	al.,	2003).	Zebrafish	wnt10b	 is	essential	 for	 the	maintenance	of	gene	expression	 in	a	portion	of	the	midbrain-hindbrain	 boundary	 (MHB),	 and	 function	 redundantly	with	wnt1;	 only	 down-regulation	 of	 both	 genes	 leads	 to	 cell	 death	 in	 the	 tectum	 and	 absence	 of	 MHB	 markers	expression	 (Lekven	 et	 al.,	 2003).	 Given	 the	 central	 role	 of	 WNT10B	 in	 hematopoietic	regeneration	after	injury	that	has	been	pointed	out	by	Congdon	and	co-workers	(Congdon	et	
al.,	2008)	and	the	up-regulation	of	WNT10B	in	AML	patients	bone	marrow	microenvironment	reported	by	Beghini	and	colleagues	(Beghini	et	al.,	2012),	we	asked	whether	zebrafish	wnt10b	expression	was	actually	present	also	 in	 the	hematopoietic	 tissues	but	resulted	undetectable	because	 of	 the	 low	 sensitivity	 of	 the	 in-situ	 hybridization	 technique	 previously	 employed	(Lekven	et	al.,	2003;	Lu	et	al.,	2011).	Our	RT-PCR	assays	on	the	RNA	selectively	extracted	from	isolated	 embryo	 caudal	 tissues,	 comprising	 hematopoietic	 territories	 (PBI,	 ICM,	 and	 CHT),	revealed	wnt10b	expression	also	in	these	regions,	supporting	the	hypothesis	of	a	physiologic	
wnt10b	role	also	in	zebrafish	hematopoiesis.	Our	forced	overexpression	of	wnt10b	during	the	embryonic	development	led,	as	expected,	to	specific	 alterations	 of	 the	 embryo	 body	 axis,	 confirming	 that	 our	 approach	 truly	 acted	misregulating	 the	Wnt	 pathway.	 Indeed,	 the	Wnt	 signaling	 in	 zebrafish	 is	 essential	 for	 the	formation	of	the	dorso-ventral	and	the	antero-posterior	axes,	depending	on	the	timing	of	its	activation.	Maternal	Wnts,	expressed	 in	 the	very	early	phases	of	development,	are	essential	for	 the	 formation	of	dorsal	 structures	 (Lu	et	al.,	 2011),	while	expression	of	 the	zygotic	Wnt	genes	plays	a	crucial	role	in	determining	the	posteriormost	structures	of	the	embryo;	indeed,	their	aberrant	activation	cause	posteriorized	phenotypes	lacking	the	anteriormost	regions	of	
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the	 head	 (van	 de	 Water	 et	 al.,	 2001;	 Beghini	 et	 al.,	 2012).	 Therefore,	 the	 phenotypes	 we	obtained	following	wnt10b	mRNA	injection,	as	enlarged	head	or,	on	the	other	hand,	absence	of	cephalic	structures,	mirror	misregulation,	respectively,	of	maternal	and	zygotic	Wnt	signaling.	(the	effects	of	the	forced	expression	of	Wnt	factors	during	zebrafish	embryonic	development	are	nicely	covered	in	Beghini	et	al.,	2012).		
Wnt10b-injected	embryos	also	show	an	accumulation	of	cells	in	ICM	and	the	severe	blockade	of	blood	circulation.	Interestingly,	this	result	resembles	what	previously	reported	by	Yeh	and	colleagues	 (Yeh	 et	 al.,	 2008),	 which	 generated	 the	 leukemic	 hsp:AML1-ETO	 zebrafish	transgenic	 line	 expressing	 the	 human	 AML-associated	 translocation	 (Kelly	 and	 Gilliland,	2002)	in	a	temporal	controlled	fashion.	Indeed,	in	the	24	hpf	embryos	of	the	hsp:AML1-ETO	line	 a	 great	 number	 of	 hematopoietic	 cells	 accumulated	 in	 the	 ICM	 region,	 blocking	 blood	circulation.	 Thus,	 our	 results	 show	 that	wnt10b	over-expression	 affect	 zebrafish	 embryonic	hematopoiesis.		To	explore	more	deeply	 the	role	of	wnt10b	in	zebrafish	hematopoiesis	and	 the	effects	of	 its	misregulation,	 we	 performed	 in-situ	 hybridization	 assays	 and	 took	 advantage	 of	 some	transgenic	reporter	line	to	perform	live	imaging	of	blood	cell	markers.	Analysis	 of	 scl	 (a	 hematopoietic	 stem	 cells	 marker)	 expression	 pattern	 after	wnt10b	over-expression	 showed	an	 increase	 in	 the	number	of	 scl-expressing	 cells	 in	 the	PBI.	 This	 result	corresponds	with	the	findings	by	Shen	and	collaborators	(Shen	et	al.,	2013),	who	generated	a	zebrafish	transgenic	line	expressing	the	murine	MYCN	oncogene	(Kawagoe	et	al.,	2007)	under	the	 control	 of	 a	 heat	 shock	 promoter.	 The	 transgenic	 embryos,	 mimicking	 human	 AML,	showed	 the	 increase	 in	 proliferation	 of	 myeloid	 cells	 and	 accumulation	 of	 immature	hematopoietic	 stem	 cells,	 with	 an	 up-regulation	 of	 scl	 and	 pu.1	 (a	 marker	 of	 myeloid	progenitors)	expression.	Our	analysis	then	focused	on	myeloid	progenitors,	through	investigation	of	pu.1	expression	in	two	 different	 stages	 of	 development:	 somitogenesis	 and	 28	 hpf.	 During	 somitogenesis,	myeloid	progenitors	are	present	in	ALM	and	PLM;	in	ALM,	they	are	initially	localized	in	two	lateral	 clusters,	 which	 later	 migrate	 toward	 the	 centre	 and	 disperse	 over	 the	 yolk	 mass.	Rhodes	 and	 co-workers	 (Rhodes	 et	 al.,	 2005),	 analysing	 pu.1	expression	 and	 its	 regulation	through	pu.1:GFP	transgenic	embryos,	 found	out	 that	myeloid	progenitors	cells,	when	begin	dispersing	 over	 the	 yolk,	 decrease	 pu.1	 expression	 and	 activate	 more	 mature	 myeloid	markers,	 indicating	 that	 migration/cell	 movement	 are	 hallmarks	 of	 differentiation.	 The	overexpression	 of	 wnt10b	 affected	 the	 myeloid	 progenitor	 migration	 pattern	 during	somitogenesis,	 leading	 to	 a	 more	 precocious	 movement	 of	 pu.1	 cells	 towards	 the	 yolk.	
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Interestingly,	 while	 such	 earlier	 migration	 was	 not	 accompanied	 by	 the	 decrease	 of	 pu.1	expression	as	expected,	we	observed	the	increase	in	the	number	of	myeloid	progenitors;	our	hypothesis	is	that	wnt10b	upregulation	expands	the	myeloid	progenitors	population	-	which	maintain	high	level	of	pu.1	expression	-	leading	to	a	defective	migration	process.		During	zebrafish	normal	embryonic	development	pu.1	physiological	expression	decreases	 in	the	course	of	the	first	day	of	development,	until	it	disappears	at	28	hpf	(Lieschke	et	al.,	2002).	
Pu.1	activity	 is	also	directly	dependent	on	scl	expression:	 indeed,	embryos	 injected	with	scl-specific	 morpholino	 (scl-deficient	 embryos)	 displayed	 a	 decrease	 in	 pu.1	 and	 gata1	 (a	erythroid	 progenitors	marker)	 expression	 at	 1	 dpf	 (Patterson	 et	al.,	 2005).	 The	 analysis	 of	myeloid	and	erythroid	progenitors	at	1	dpf	in	wnt10b-injected	embryos	showed	an	increase	in	the	 number	 of	 these	 cell	 populations.	 On	 the	 basis	 of	 the	 higher	 number	 of	 myeloid	 and	erythroid	progenitors	 and	 the	 increase	 in	 the	 scl-positive	 cells	we	determined	by	means	 of	
wnt10b	 forced	 expression,	 we	 propose	 that	wnt10b	 might	 function	 upstream	 of	 scl	 in	 the	genetic	 hierarchy	 required	 for	 proper	 zebrafish	 hematopoiesis.	 Indeed,	 a	 similar	 hierarchy	was	also	proposed	by	Tarafdar	and	colleagues,	that	using	a	HSCs	in-vitro	model	in	which	beta-catenin	was	upregulated,	pointed	out	 that	 scl	was	positively	 regulated	by	 the	Wnt	pathway		(Tarafdar	et	al.,	2013).		Since	 human	 AML	 is	 characterized	 by	 an	 increase	 of	 myeloid	 cells	 arrested	 in	 their	maturation,	resulting	in	granulocytopenia	or	anemia	(Lowenberg	et	al.,	1999),	we	decided	to	analyse	 neutrophils	 and	 erythrocytes	 number	 and	 distribution	 following	wnt10b	 injection.	Through	 live	 imaging	 of	 transgenic	 mpx:GFP	 embryos	 (characterized	 by	 fluorescent	neutrophils)	 we	 pointed	 out	 the	 decrease	 in	 the	 number	 of	 differentiated	 neutrophils	 in	
wnt10b-injected	 embryos;	 this	 result	 is	 in	 contrast	with	 those	 presented	 so	 far	 (Yeh	 et	al.,	2008,	Patterson	et	al.,	2005,	 Shen	et	al.,	2013),	which	pointed	out	 the	direct	dependence	of	
mpx	 expression	 upon	 pu.1:	 mutants	 with	 deregulated	 pu.1,	 as	 well	 as	 zebrafish	 models	 of	leukemias	 developed	 by	 now,	 show	 the	 simultaneous	 increase	 in	 both	 pu.1	 and	 mpx	expression.	Besides	the	fact	that	our	approach	is	based	on	transient	misregulation	of	the	gene	of	interest,	while	the	zebrafish	leukemia	models	reported	above	are	generated	through	stable	transgenesis	or	mutation,	these	partially	discordant	results	could	also	be	explained	by	the	fact	that	WNT10B	 is	heavily	 involved	 in	hematopoiesis,	hematopoietic	regeneration,	and	disease	states	(Mikesch	et	al.,	2007,	Congdon	et	al.,	2008,	Beghini	et	al.,	2012),	so	it	might	have	a	more	widespread	 role,	 affecting	 different	 pathways,	 with	multifaceted	 effects	 on	 zebrafish	 blood	development.	 The	 hypothesis	 is	 that,	 also	 in	 zebrafish,	 wnt10b	 may	 regulate	 the	proliferation/differentiation	 balance	 of	 HSCs,	 acting	 upstream	 of	 scl.	 pu.1,	 gata1	 and	 other	
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hematopoietic	markers.	Moreover,	the	accumulation	of	myeloid	progenitors	in	hematopoietic	tissues	 and	 the	 decrease	 of	 more	 differentiated	 myeloid	 cells	 in	wnt10b-injected	 embryos	resemble	 granulocytopenia,	 one	 feature	 of	 leukemic	 disorders,	 caused	 by	 the	 over-proliferation	of	myeloid	progenitors	(Lowenberg	et	al.,	1999).		Our	 subsequent	 analysis	 regarded	 the	 number	 and	distribution	 of	 erythrocytes	 population;	the	results	obtained	through	o-dianisidine	staining	did	not	show	a	significant	decrease	in	the	differentiated	population	after	wnt10b	overexpression.	Additionally,	more	sensitive	analyses,	as	RT-PCR	for	globin	genes,	need	to	be	performed.		Taken	together,	our	results	support	the	involvement	of	wnt10b	in	Vertebrate	hematopoiesis,	which	 might	 regulate	 the	 delicate	 proliferation/differentiation	 balance	 of	 blood	 cell	progenitors.	On	 the	 basis	 of	 the	 encouraging	 results	 presented	 in	 this	 thesis,	 our	 next	 step	 will	 be	 the	generation	of	a	zebrafish	transgenic	 line	expressing	wnt10b	 in	a	temporal	 inducible	 fashion,	specifically	in	the	hematopoietic	stem	cells.	To	restrict	the	expression	of	the	transgene	in	the	hematopoietic	territories,	the	zebrafish	runx1	promoter	has	been	selected.	Runx1	is	essential	in	 definitive	 hematopoiesis,	 and	 gene	 structure	 and	 function	 are	 conserved	 among	Vertebrates.	 Runx1	 is	 expressed	 in	 all	 definitive	 hematopoiesis	 sites	 in	 mammals	 and	zebrafish	(North	et	al.,	2002;	Kalev-Zylinska et	al.,	2002),	as	also	demonstrated	through	the	construction	of	 a	 transgenic	runx1:EGFP	zebrafish	 line,	 in	which	EGFP	expression	marks	all	sites	of	runx1	expression	during	development	and	adulthood	(Lam	et	al.,	2009).		We	have	generated	a	construct,	named	pBluescript	II	SK_runx1P2_wnt10b+polyA_L200_R150,	in	which	wnt10b	coding	sequence	is	under	the	control	of	the	runx1	promoter	that	will	allow	to	drive	wnt10b	expression	in	definitive	hematopoietic	tissues,	as	the	embryonic	AGM	and	the	adult	 kidney	 (Lam	 et	 al.,	 2009).	 The	 transgene	 is	 flanked	 by	 the	 transposable	 elements	 in	order	to	dramatically	increase	the	rate	of	transgenesis	(Kawakami	et	al.,	2007). The	 generation	 of	 this	 transgenic	 line	 will	 give	 the	 opportunity	 to	 deepen	 our	 knowledge	about	the	involvement	of	WNT10B	in	Vertebrate	hematopoiesis	and,	possibly,	to	elucidate	the	mechanism	by	which	this	gene	is	involved	in	the	onset	and	progression	of	AML.	
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